Epilepsy Awareness Month Conference Announced
* Reuters is not responsible for the content in this press release.
"Epilepsy Topics Speak to Seizure Disorders Community" SEATTLE, Oct. 23 /PRNewswire-USNewswire/ -- The Epilepsy Foundation Northwest announced the annual November Epilepsy Awareness Month Conference to be held at Seattle Children's Hospital in Seattle on Saturday, November 8 from 8:30 a.m. to 4:00 p.m. The educational seminars are open to the public and will provide information about a variety of topics surrounding epilepsy. The speakers and topics for the conference include: David Vossler, M.D., Medical Director, Washington Neuroscience Institute, Valley Medical Center "Current and Future Medications: Selecting the Correct Antiepileptic Drug" Hillary Shurtleff, Ph.D., UW Medicine, Seattle Children's Hospital "How School Learning is Affected by Prescription Drugs" Jeff Ojemann, M.D., UW Medicine, Seattle Children's Hospital "Surgical Options for Epilepsy in Children" Regina Chacon, Outreach Director, Washington Prescription Drug Program "Getting the Most Out of WPDP" Anne M. Kysar, Esq., Schroeter, Goldmark & Bender "Epilepsy & Social Security Disability" Dana Hess, Lead Civil Rights Investigator, Washington Human Rights Commission "Disability Rights in Washington" For specific conference information, go to www.epilepsynw.org. To register email name and contact information to: mail@epilepsynw.org or call 800-752-3509. Epilepsy Foundation Northwest (EFNW) is the principal advocate for the epilepsy community in Oregon and Washington. EFNW helps to ensure people with seizures are able to participate in all life experiences; and works to prevent, control and cure epilepsy through services, education, advocacy and research. Nearly 63,000 people in Washington and 37,000 people in Oregon are living with epilepsy or seizure related conditions. SOURCE Epilepsy Foundation Northwest Brent Herrmann of the Epilepsy Foundation Northwest, +1-206-547-4551, mail@epilepsynw.org
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters